AMICUS THERAPEUTICS INC. - COMMON STOCK
9,6600
22-ноября-24 16:44:58
15 мин. задержка
Акции
+0,1600
+1,68%
Сегодняшний диапазон
9,4600 - 9,7800
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in March 2024
01 мар 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
28 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
15 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
08 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentations and Posters at the 20th Annual WORLDSymposium™ 2024
01 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook
07 янв 2024 16:00:52 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 янв 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
NetDania - New 12 months High: AMICUS THERAPEUTICS INC. - COMMON STOCK
28 дек 2023 09:55:27 Источник NetDania Notify
-
NetDania - New 12 months High: AMICUS THERAPEUTICS INC. - COMMON STOCK
27 дек 2023 09:45:13 Источник NetDania Notify
-
NetDania - New 12 months High: AMICUS THERAPEUTICS INC. - COMMON STOCK
26 дек 2023 15:40:25 Источник NetDania Notify
-
05 дек 2023 06:00:38 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Third Quarter 2023 Financial Results and Corporate Updates
08 ноя 2023 07:00:01 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2023
01 ноя 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Announce Third Quarter 2023 Financial Results on November 8, 2023
27 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentation and Posters at World Muscle Society 2023
03 окт 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics and Blackstone Enter into $430 Million Strategic Financing Collaboration
02 окт 2023 08:20:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease
28 сен 2023 10:41:45 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023
01 сен 2023 07:00:18 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023
29 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire
-
Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer
21 авг 2023 07:00:00 Источник Nasdaq GlobeNewswire